• Space

    EXM is a non-recreational cannabis company, focused on the medical and nutraceutical uses of the compounds found within the plant.

    Learn More
  • Space

    Our relentless focus on innovation will drive revolution in the cannabis industry for years to come

    Learn More
  • Space

    Our experts come from diverse backgrounds in traditional extraction and large-scale distillation

    Learn More
  • Space

    Innovation in refining and next-generation product drive our advantage in Portugal

    Learn More
  • Space

    Revenue Growth based on Cost Competitive Cultivation and High Yield Extraction

    Learn More
  • Space

    Massive cultivation potential from our assets

    Learn More
  • Space

    We are committed to developing strong partnerships and a long-lasting positive impact

    Learn More

Medical grade ingredients

EXMceuticals (“EXM”) is a medical cannabis company that strongly believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with high ambitions and potential in becoming one of the lowest-cost producers of high-grade cannabis and hemp ingredients in the world. We focus on providing the right ingredients to consumer goods infused products, capsules and oils for the medicinal and wellness industry.

EXMceuticals_icons_extract.png

Research Driven

Research-driven in cannabis extraction, distillation, purification and cannabinoid isolation with industry leading scientists

EXMceuticals_icons_organic.png

Innovation

Fully operational R&D laboratory in Portugal will now develop cannabis-based formulations for products and operate as a pilot-scale refinery for the transformation of cannabis-based ingredients.

EXMceuticals_icons_medical.png

Medical

Focused on providing the right ingredients to consumer goods infused products, capsules and oils for the medicinal and wellness industry.We control our cultivation, extraction, refining and manufacturing practices

Exchange Price % Move
CSE:EXM
FSE:A2PAW2

Investor information

EXMceuticals Inc. Sets Sights On €200 Billion value on European and US combined cannabis market.

Our Portugal R&D and refinery hub is designed for purifying the extracts produced by EXMFarming and will serve as the gateway to distribute manufactured materials in Europe and North America.

Learn more

Updates

News

Latest News

Access our latest news

lab-217041.jpg

Research and Development

EXMceuticals's fully operational R&D laboratory in Portugal will now develop cannabis-based formulations for products and operate as a pilot-scale refinery ...

Lab.jpeg

EXMceuticals obtains its research and development

EXMceuticals Portugal has obtained the authorization for cannabis research and development from INFARMED, the Portuguese National Authority of Medicines and ...

2% of the gross revenues from each of our plantations is allocated to projects that will improve living conditions and further the development of local communities. Projects include clean drinking water, education and sustainable production of food crops.

Learn More